Sencure

Sencure is a Dutch healthtech company specializing in the design and manufacture of ultra-low-power integrated circuits (ICs) tailored for wearable medical devices and advanced health-tracking systems. Spun out from ItoM Medical B.V. in 2021, the company leverages deep expertise in electrophysiology and semiconductor design to provide high-performance sensing solutions for ECG, EMG, and EEG monitoring. Their technology is critical for remote patient monitoring, clinical research, and consumer health applications, enabling manufacturers to create smaller, more efficient devices that meet stringent medical regulatory standards. Headquartered in Roden, Netherlands, Sencure operates at the intersection of hardware innovation and biomedical data analysis. By offering both proprietary chip technology, such as their flagship SNCE800, and comprehensive system engineering support, the company helps partners navigate complex regulatory landscapes like MDR and IEC 60601-1. With recent funding rounds supporting their commercial expansion, Sencure is positioned as a key enabler for the next generation of medical-grade wearables.

Sencure’s mission is to revolutionize patient monitoring and health tracking—both directly and through strategic partnerships—by developing integrated biosensor technology that accelerates healthcare innovation and positively impacts people’s lives.

• Successfully raised over $14 million in total funding as of 2025.
• Developed the SNCE800, a high-performance integrated circuit for bioelectrical measurements.
• Spun out from the established semiconductor design firm ItoM Medical B.V.
• Provides critical regulatory support for medical device manufacturers navigating MDR and IEC 60601-1.

Sources

• Sencure Official Website
• LinkedIn - Sencure
• Silicon Canals
• PitchBook